Industries > Pharma > Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029

Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029

Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Roche, Siemens AG, Sysmex, Other Companies

PUBLISHED: 14 May 2019
PAGES: 204
PRODUCT CODE: PHA0420
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0420 Categories: , Tags: , , , , , ,

The global in vitro diagnostics (IVD) market is estimated to have reached $69.2bn in 2018. The largest sector of the IVD market in 2018 was point of care diagnostics segment, generating sales of $19.4bn in 2018, which accounted for 28.0% of overall IVD sales.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 204-page report you will receive 180 charts– all unavailable elsewhere.

The 204-page report provides clear detailed insight into the leading in vitro diagnostics (IVD) companies. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• In Vitro Diagnostics (IVD) revenues in 2017 and 2018 by Class:
• Point-of-Care
• Clinical Chemistry
• Immunochemistry
• Hematology
• Microbiology
• Genetic Testing
• Others

• In Vitro Diagnostics (IVD) revenue forecast for 2019, 2024 and 2029 by Class:
• Point-of-Care
• Clinical Chemistry
• Immunochemistry
• Hematology
• Microbiology
• Genetic Testing
• Others

• This report profiles and discusses the selected leading in vitro diagnostics (IVD) companies:
• Abbott Laboratories
• Arkray, Inc.
• Becton, Dickinson and Company (BD)
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Dako (Agilent Technologies)
• Danaher Corporation
• Genomic Health
• Laboratory Corporation of America (LabCorp)
• MDxHealth
• Myriad Genetics
• QIAGEN
• Roche
• Siemens AG
• Sysmex Corporation
• Thermo Fisher Scientific
• Other companies

Top In Vitro Diagnostics (IVD) Companies 2019-2029

• This report discusses sales and recent performance analysis, key products, strengths and challenges, historical revenues, revenue forecast, market share forecast, mergers and acquisition (M&A) activity, strategic collaborations

• Analysis of factors that drive and restrain the in vitro diagnostics (IVD) market.
• Key Questions Answered by this Report:
• Who are the leading IVD manufacturers?
• What factors are driving and restraining growth for the leading IVD manufacturers?
• How have the leading IVD manufacturers performed financially in recent years?
• Which IVD manufacturers will experience revenue growth over the coming years?
• What are the strength and weakness of the leading IVD manufacturers?
• What strategies have IVD manufacturers been implementing for sales growth in recent years?

Visiongain’s study is intended for anyone requiring commercial analyses for the leading in vitro diagnostics (IVD) companies. You find data, trends and predictions.

Buy our report today Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029: Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Roche, Siemens AG, Sysmex, Other Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029


Latest Pharma news

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Visiongain Publishes Clinical Perinatal Software Market Report 2020-2030

Various research studies are currently underway, which are expected to create a competitive advantage for manufacturers to develop new and innovative and advanced software that is expected to provide a variety of additional opportunities in the perinatal clinical software market.

01 July 2020

READ

Visiongain publishes Clinical Laboratory Tests Market Report 2020-2030

Growing investment in target diagnosis of cardiovascular disorders, TB and diabetes drives demand for clinical laboratory testing. Clinical lab tests help in diagnosing mellitus diabetes. According to the International Diabetes Federation article published in 2019, some 463 million adults were diabetic, and it is estimated that it will reach 700 million worldwide by 2045.

01 July 2020

READ

Categories